Guangxi Beisheng Pharmaceutical Co. Ltd is mainly engaged in the manufacture and sale of hi-tech pharmaceuticals such as genetic engineering products, biochemical and biological medicines, human tissue engineering materials and blood products, as well as drugs and traditional Chinese medicines. The company benefits from the use of advance equipment by importing fermenting and filtering equipment from overseas.

Guangxi Beishen researched and developed type J-I shed cell variant dermis, which has been included in the 'National Torch Program' and has been awarded a United States patent. The company and its subsidiaries have passed National GMP certification and are located in a 40,000-square-metre GMP facility. It has been recognised as one of the key hi-tech biopharmaceutical enterprises in Guangxi Autonomous Region.